Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PharmAthene Inc (NYSE MKT LLC:PIP)

0.9251
Delayed Data
As of Feb 24
 +0.0151 / +1.66%
Today’s Change
0.18
Today|||52-Week Range
1.47
+140.86%
Year-to-Date
SECTOR
Commercial Services
INDUSTRY
Miscellaneous Commercial Services
MARKET CAP
$61.7M

Company Description

PharmAthene, Inc. operates as a biodefense company. The company is engaged in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD.

Contact Information

PharmAthene, Inc.
One Park Place
Annapolis Maryland 21401
P:(410) 269-2600
Investor Relations:

Employees

Shareholders

Individual stakeholders38.12%
Other institutional31.83%
Mutual fund holders12.01%

Top Executives

John M. GillPresident, Chief Executive Officer & Director
Philip MacNeillCFO, Secretary, Treasurer & Vice President
Jeffrey SteinbergVice President-Corporate & Business Development
John TroyerVice President-Product Development